IDO1 and hepatocellular carcinoma: Together, IDO dysregulation has been recorded in patients with viral hepatitis (15, 17), liver transplant (18, 19), autoimmune hepatitis (20) as well as hepatocellular carcinoma (HCC) (21, 22).